FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Peterson Amy C. |
2. Issuer Name
and
Ticker or Trading Symbol
BeiGene, Ltd. [ BGNE ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) CMO, Immuno-oncology |
C/O MOURANT OZANNES CORPORATE SERVICES,, 94 SOLARIS AVENUE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
CAMANA BAY, GRAND CAYMAN, E9 KY1-1108 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Ordinary Shares | 194569 | D | ||||||||
American Depositary Shares (1) | 11/8/2018 | M | 14711 | A | $29.10 (2) | 14711 | D | |||
American Depositary Shares (1) | 11/8/2018 | S (3) | 466 | D | $122.8565 (4) | 14245 | D | |||
American Depositary Shares (1) | 11/8/2018 | S (3) | 2423 | D | $124.4759 (5) | 11822 | D | |||
American Depositary Shares (1) | 11/8/2018 | S (3) | 3949 | D | $126.0773 (6) | 7873 | D | |||
American Depositary Shares (1) | 11/8/2018 | S (3) | 7673 | D | $126.7197 (7) | 200 | D | |||
American Depositary Shares (1) | 11/8/2018 | S (3) | 200 | D | $127.6075 (8) | 0 | D | |||
American Depositary Shares (1) | 11/9/2018 | M | 13222 | A | $29.10 (2) | 13222 | D | |||
American Depositary Shares (1) | 11/9/2018 | S (3) | 4031 | D | $118.635 (9) | 9191 | D | |||
American Depositary Shares (1) | 11/9/2018 | S (3) | 1725 | D | $119.2694 (10) | 7466 | D | |||
American Depositary Shares (1) | 11/9/2018 | S (3) | 2100 | D | $120.631 (11) | 5366 | D | |||
American Depositary Shares (1) | 11/9/2018 | S (3) | 2898 | D | $121.7059 (12) | 2468 | D | |||
American Depositary Shares (1) | 11/9/2018 | S (3) | 2046 | D | $122.5478 (13) | 422 | D | |||
American Depositary Shares (1) | 11/9/2018 | S (3) | 322 | D | $123.7476 (14) | 100 | D | |||
American Depositary Shares (1) | 11/9/2018 | S (3) | 100 | D | $125.97 (15) | 0 | D | |||
American Depositary Shares (1) | 11/12/2018 | M | 12067 | A | $29.10 (2) | 12067 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 2958 | D | $111.1013 (16) | 9109 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 4000 | D | $112.1801 (17) | 5109 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 2527 | D | $113.0322 (18) | 2582 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 1173 | D | $113.9216 (19) | 1409 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 700 | D | $114.96 (20) | 709 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 500 | D | $116.5623 (21) | 209 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 109 | D | $117.6106 (22) | 100 | D | |||
American Depositary Shares (1) | 11/12/2018 | S (3) | 100 | D | $121.56 (23) | 0 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Share Option (Right to Buy) | $2.24 (24) | 11/8/2018 | M | 191243 | (25) | 8/21/2026 | Ordinary Shares | 191243.0 | $0 | 1408757 | D | ||||
Share Option (Right to Buy) | $2.24 (24) | 11/9/2018 | M | 171886 | (25) | 8/21/2026 | Ordinary Shares | 171886.0 | $0 | 1236871 | D | ||||
Share Option (Right to Buy) | $2.24 (24) | 11/12/2018 | M | 156871 | (25) | 8/21/2026 | Ordinary Shares | 156871.0 | $0 | 1080000 | D |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Peterson Amy C.
C/O MOURANT OZANNES CORPORATE SERVICES, 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN, E9 KY1-1108 |
|
|
CMO, Immuno-oncology |
|
Signatures
|
||
/s/ Scott A. Samuels, as Attorney-in-Fact | 11/12/2018 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |